HEALTH-TECH

Amends the Compassionate Use of Medical Cannabis Pilot Program Act. Makes a technical change in a Section concerning the short title. House Committee Amendment No. 1 Adds reference to: 10 ILCS 5/9-45 30 ILCS 500/1-10 35 ILCS 5/201 from Ch. 120, par. 2-201 35 ILCS 105/3-10 35 ILCS 110/3-10 from Ch. 120, par. 439.33-10 35 ILCS 115/3-10 from Ch. 120, par. 439.103-10 35 ILCS 120/2-10 105 ILCS 5/22-33 225 ILCS 60/22 from Ch. 111, par. 4400-22 410 ILCS 130/7 410 ILCS 130/10 410 ILCS 130/30 410 ILCS 130/35 410 ILCS 130/36 410 ILCS 130/55 410 ILCS 130/57 410 ILCS 130/62 410 ILCS 130/75 410 ILCS 130/130 410 ILCS 130/195 410 ILCS 130/200 410 ILCS 130/135 rep. 410 ILCS 130/220 rep. 625 ILCS 5/2-118.2 625 ILCS 5/6-206.1 from Ch. 95 1/2, par. 6-206.1 625 ILCS 5/11-501 from Ch. 95 1/2, par. 11-501 625 ILCS 5/11-501.9 720 ILCS 550/5.3 Replaces everything after the enacting clause. Amends the Compassionate Use of Medical Cannabis Pilot Program Act. Removes the word "Pilot" from the Act's short title and the Compassionate Use of Medical Cannabis Pilot Program. Makes conforming changes throughout the Act and statutes. Provides that autism, chronic pain, irritable bowel syndrome, migraines, osteoarthritis, anorexia nervosa, Ehlers-Danlos Syndrome, Neuro-Behcet's Autoimmune Disease, neuropathy, polycystic kidney disease, superior canal dehiscence syndrome, and medical conditions or symptoms for which a person may benefit from the use of medical cannabis are debilitating medical conditions. Provides that possessing cannabis in a vehicle not open to the public unless the medical cannabis is in a reasonably secured, sealed, container (rather than a tamper-evident container) and reasonably inaccessible while the vehicle is moving is not permitted. Removes language providing that a physician may not accept, solicit, or offer any form of remuneration from or to a qualifying patient, primary caregiver, cultivation center, or dispensing organization other than accepting payment from a patient for the fee associated with a required examination. Provides that a qualifying patient under the age of 18 shall not be prohibited from having up to 3 (instead of 2) designated caregivers. Provides that the Department of Public Health shall establish procedures to permit qualified veterans to participate in the Opioid Alternative Pilot Program. Provides that any Department of Public Health-approved quantity waiver process must be made available to qualified veterans. Provides that the Department of Public Health shall provide for immediate changes to a registered qualifying patient's designated registered dispensing organization. Provides that the Department of Financial and Professional Regulation shall adopt rules permitting returns, and potential refunds, for damaged or inadequate products. Repeals a provision concerning changing a designated dispensing organization. Repeals a provision repealing the Act on July 1, 2020.